Incannex executes strategic cancellation of 50.4% of Series A warrants

Incannex (IXHL) Healthcare announced the completion of a $16.7M gross proceeds capital raise through its at-the-market facility. $12.5M of these proceeds will be used to cancel up to 50.4% of the Series A Warrants previously issued as part of a prior financing agreement. This strategic initiative significantly reduces potential future dilution attributable to the Series A Warrants, with up to 5,841,038 of these warrants eligible for cancellation. If triggered, the adjustment features of these Series A Warrants could otherwise have resulted in up to 175.2M additional shares being issued. This move underscores Incannex’s proactive approach to capitalization management and shareholder alignment.